{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:18:40Z","timestamp":1741238320104,"version":"3.38.0"},"reference-count":106,"publisher":"JLE","issue":"6","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.nephro.2007.04.002","type":"journal-article","created":{"date-parts":[[2007,7,31]],"date-time":"2007-07-31T11:58:03Z","timestamp":1185883083000},"page":"392-426","source":"Crossref","is-referenced-by-count":5,"title":["Th\u00e9rapeutique diur\u00e9tique"],"prefix":"10.1684","volume":"3","author":[{"given":"Claire","family":"Presne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Monge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janette","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Oprisiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Choukroun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Michel","family":"Achard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2007.04.002_bib1","series-title":"Les diur\u00e9tiques","first-page":"80","article-title":"Pharmacocin\u00e9tique des diur\u00e9tiques","author":"Billard","year":"1998"},{"key":"10.1016\/j.nephro.2007.04.002_bib2","series-title":"M\u00e9canismes de r\u00e9sistance aux diur\u00e9tiques\u2013Cons\u00e9quences cliniques. Actualit\u00e9s N\u00e9phrologiques","first-page":"387","author":"Brater","year":"1992"},{"key":"10.1016\/j.nephro.2007.04.002_bib3","series-title":"Comprehensive Clinical Nephrology","article-title":"Normal acid base balance and metabolic acidosis","author":"Palmer","year":"2000"},{"key":"10.1016\/j.nephro.2007.04.002_bib4","first-page":"2679","article-title":"Action and clinical use of diuretics. Oxford textbook of clinical nephrology","author":"Greger","year":"1998"},{"key":"10.1016\/j.nephro.2007.04.002_bib5","first-page":"705","article-title":"La th\u00e9rapeutique diur\u00e9tique moderne: bases physiopathologiques","volume":"78","author":"Fournier","year":"1970","journal-title":"Presse Med."},{"key":"10.1016\/j.nephro.2007.04.002_bib6","doi-asserted-by":"crossref","first-page":"3Q","DOI":"10.1016\/S0002-9149(99)00691-8","article-title":"Pathophysiology and differential diagnosis of neurocardiogenic syncope","volume":"84","author":"Grubb","year":"1999","journal-title":"Am. J. Cardiol."},{"year":"2000","series-title":"Disorder of water metabolism. Clinical Nephrology","author":"Berl","key":"10.1016\/j.nephro.2007.04.002_bib7"},{"key":"10.1016\/j.nephro.2007.04.002_bib8","series-title":"Les diur\u00e9tiques","first-page":"335","article-title":"Effets ind\u00e9sirables des diur\u00e9tiques","author":"Andrejak","year":"1998"},{"key":"10.1016\/j.nephro.2007.04.002_bib9","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0024-3205(99)00330-6","article-title":"Contribution of vasopressin to progression of chronic renal failure; study in Brattleboro rats","volume":"65","author":"Bouby","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.nephro.2007.04.002_bib10","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2007.04.002_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000186456","article-title":"A novel treatment of idiopathic oedema of women","volume":"58","author":"Edwards","year":"1991","journal-title":"Nephron"},{"key":"10.1016\/j.nephro.2007.04.002_bib12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(00)02527-7","article-title":"Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the Internation nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)","volume":"356","author":"Brown","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-5273(01)00600-3","article-title":"Current evidence supporting the role of diuretics in heart failure: a metaanalysis of randomised controlled trials","volume":"82","author":"Faris","year":"2002","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.nephro.2007.04.002_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(97)08417-1","article-title":"Randomized trial of high dose isosorbide dinitrate plus low dose furosemide versus high dose furosemide plus low dose isosorbide dinitrate in severe pulmonary oedema","volume":"351","author":"Cotter","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib15","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1161\/01.CIR.0000109205.35813.8E","article-title":"Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure?","volume":"108","author":"Packer","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.nephro.2007.04.002_bib16","first-page":"27","article-title":"Validation du recueil des urines de 24\u00a0heures par l'estimation de la cr\u00e9atininurie des 24\u00a0heures d'apr\u00e8s la formule de Cockroft et Gault","volume":"21","author":"Fournier","year":"2000","journal-title":"Nephrologie"},{"key":"10.1016\/j.nephro.2007.04.002_bib17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archinte.160.6.777","article-title":"Consumption of NSAID and the development of congestive heart failure in elderly patients. An unrecognized Public Health Problem","volume":"160","author":"Page","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.nephro.2007.04.002_bib18","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","article-title":"Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial - the Losartan Heart Failure Survival Study ELITE II","volume":"355","author":"Pitt","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib19","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunctions after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 35A","key":"10.1016\/j.nephro.2007.04.002_bib20","first-page":"212A","article-title":"The benefit of spironolactone in the RALES trial is not primarily due to a diuretic effect","volume":"35","author":"Cody","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"Suppl. 2","key":"10.1016\/j.nephro.2007.04.002_bib21","first-page":"203A","article-title":"Survival benefits of spironolactone therapy may be explained by the limitation of the excessive extracellular matrix turnover in patients with CHF: insights from the RALES trial","volume":"35","author":"Zannad","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.nephro.2007.04.002_bib22","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/01.CIR.0000014763.63528.9D","article-title":"New therapeutic options in congestive heart failure","volume":"105","author":"Mac Murray","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.nephro.2007.04.002_bib23","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0735-1097(01)01683-7","article-title":"ACC\/AHA guidelines for the evaluation and management of chronic heart failure in the adult","volume":"38","author":"Hunt","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.nephro.2007.04.002_bib24","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long term ACE inhibitor therapy in patients with heart failure of left ventricular dysfunction: a systematic overreview of data from individual patients. ACE Inhibitor Myocardial Infarction Collaborative Group","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib25","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(03)13501-5","article-title":"Effect of enalapril on 12\u00a0years survival and life expectancy in patients with left ventricular dysfunction: a follow-up study","volume":"361","author":"Jong","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib26","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.101.5.558","article-title":"\u03b2 adrenergic receptor blockade in chronic heart failure","volume":"101","author":"Bristow","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.nephro.2007.04.002_bib27","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Committee of the OPTIMAAL Study Group: Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib28","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nephro.2007.04.002_bib29","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"Valsartan Heart Failure Trial Investigators: A randomized trial of angiotensin receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nephro.2007.04.002_bib30","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"CHARM Investigators and Committees: Effect of candesartan in patients with chronic heart failure and reduced left ventricular systolic function intolerant to angiotensin enzyme inhibitors: the CHARM-alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effect of candesartan in patients with chronic heart failure and reduced left ventricular systolic function taking angiotensin converting enzyme inhibitors: the CHARM-added trial","volume":"362","author":"Mac Murray","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib32","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction. The CHARM-preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(00)02602-7","article-title":"Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomized trial","volume":"356","author":"Rouleau","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib34","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/01.CIR.0000029801.86489.50","article-title":"Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE)","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.nephro.2007.04.002_bib35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nephro.2007.04.002_bib36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0002-9343(88)90590-6","article-title":"Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by head-out water immersion in sodium-retaining cirrhotic subjects","volume":"85","author":"Skorecki","year":"1988","journal-title":"Am. J. Med."},{"key":"10.1016\/j.nephro.2007.04.002_bib37","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0168-8278(97)80456-4","article-title":"Natriuretic response to the combination of atrial natriuretic peptide and tertipressin in patients with cirrhosis and refractory ascites","volume":"26","author":"Gadano","year":"1997","journal-title":"J. Hepatol."},{"issue":"86","key":"10.1016\/j.nephro.2007.04.002_bib38","first-page":"220","article-title":"Terlipressin. Type I hepatorenal syndrome: an extra window of time before liver transplantation","volume":"15","year":"2006","journal-title":"Prescrire Int. Dec"},{"key":"10.1016\/j.nephro.2007.04.002_bib39","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gin\u00e8s","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib40","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.V114604","article-title":"Collecting duct Na, K-ATPase activity correlates with urinary sodium excretion in rat nephrotic syndromes","volume":"11","author":"Desch\u00eanes","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.nephro.2007.04.002_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(03)12229-5","article-title":"Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial","volume":"361","author":"Nakao","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib42","series-title":"Les diur\u00e9tiques","first-page":"263","article-title":"\u0152d\u00e8mes et diur\u00e9tiques","author":"Tribout","year":"1998"},{"key":"10.1016\/j.nephro.2007.04.002_bib43","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1681\/ASN.V123598","article-title":"Collecting duct is a site of sodium retention in PAN nephrosis: a rationale for amiloride therapy","volume":"12","author":"Desch\u00eanes","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.nephro.2007.04.002_bib44","series-title":"Actualit\u00e9s n\u00e9phrologiques","first-page":"81","article-title":"Physiopathologie des \u0153d\u00e8mes et de l'insuffisance r\u00e9nale aigu\u00eb dans le syndrome n\u00e9phrotique idiopathique","author":"Koomans","year":"2000"},{"key":"10.1016\/j.nephro.2007.04.002_bib45","unstructured":"Cantarovich F, Lorenz H. More patients (pts) with acute renal failure (ARF) requiring hemodialysis (HD) and receiving high dose furosemide (HF) reach early two-liter diuresis than pts on placebo (P) and may have shorter. J. Am. Soc. Nephrol. Abstract of 33rd annual Meeting, 2000."},{"key":"10.1016\/j.nephro.2007.04.002_bib46","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0895-7061(98)00158-7","article-title":"Pharmacologic treament of hypertension in the department of Veterans Affairs during 1995 and 1996","volume":"11","author":"Siegel","year":"1998","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.nephro.2007.04.002_bib47","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.jhh.1000917","article-title":"Guidelines for management of hypertension: report of the third working party for the British Hypertension Society","volume":"13","author":"Ramsay","year":"1999","journal-title":"J. Hum. Hypertens."},{"issue":"8","key":"10.1016\/j.nephro.2007.04.002_bib48","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jacc.2003.10.060","article-title":"Cerebroprotection mediated by angiotensin II (AT2)-receptors. A hypothesis supported by recent randomised trials","volume":"43","author":"Fournier","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.nephro.2007.04.002_bib49","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in High-Risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2007.04.002_bib50","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","article-title":"Major cardiovascular events in hypertensive patients randomized to Doxazosin vs Chlorthalidone","volume":"283","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2007.04.002_bib51","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMoa021716","article-title":"Second Australian National Blood Pressure Study (ANBP2). A comparison of ACE inhibitors and diuretics for hypertension in the elderly","volume":"348","author":"Wing","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nephro.2007.04.002_bib52","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/00004872-200018100-00015","article-title":"on behalf of the LIVE investigators: Regression of left ventricular hypertrophy in hypertensive patients treated with indapamid SR1.5 versus enalapril 20. The LIVE Study","volume":"10","author":"Gosse","year":"2000","journal-title":"J. Hypertens."},{"key":"10.1016\/j.nephro.2007.04.002_bib53","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/01.CIR.91.3.698","article-title":"Comparison of five antihypertensive monotherapy and placebo for change in left ventricular mass in patients receiving nutritional hygienic therapy in the treatment of mild hypertension study (TOMHS)","volume":"91","author":"Liebson","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.nephro.2007.04.002_bib54","series-title":"Les diur\u00e9tiques","first-page":"229","article-title":"Regression de l'HVG chez l'hypertendu. Effet des diur\u00e9tiques et r\u00f4le du sodium","author":"du Cailar","year":"1998"},{"key":"10.1016\/j.nephro.2007.04.002_bib55","series-title":"Les diur\u00e9tiques","first-page":"105","article-title":"Art\u00e8res de gros calibres et traitement diur\u00e9tique dans l'hypertension art\u00e9rielle","author":"Safar","year":"1998"},{"key":"10.1016\/j.nephro.2007.04.002_bib56","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","article-title":"Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the captopril prevention project (CAPPP) randomised trial","volume":"353","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib57","first-page":"17","article-title":"Results of the STOP-Hypertension-2 trial","volume":"S2","author":"Hansson","year":"2001","journal-title":"Blood Press"},{"key":"10.1016\/j.nephro.2007.04.002_bib58","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(00)02526-5","article-title":"for the NORDIL study group: Randomised trial of effects of calcium antagonists compared with diuretics and \u00df-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study","volume":"356","author":"Hansson","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib59","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","article-title":"BLP trialist collaboration: Effect of different blood pressure lowering regimens on major cardiovascular events: results of propstective designed aver reviews of randomised trials","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib60","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1001\/jama.289.19.2534","article-title":"Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis","volume":"289","author":"Psaty","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2007.04.002_bib61","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.amjhyper.2003.07.012","article-title":"Tolerability and treatment compliance with angiotensin II receptor antagonist","volume":"16","author":"Mancia","year":"2003","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.nephro.2007.04.002_bib62","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the joint national committee on prevention, detection, evaluation and treatment of highblood pressures","volume":"289","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2007.04.002_bib63","series-title":"Trait\u00e9 de m\u00e9decine interne","first-page":"1","article-title":"Hypertension art\u00e9rielle","author":"Fournier","year":"2004"},{"key":"10.1016\/j.nephro.2007.04.002_bib64","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0006-2952(01)00687-6","article-title":"Protection against ischemia: a physiological function of the renin angiotensin system","volume":"62","author":"Achard","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nephro.2007.04.002_bib65","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/00004872-199209000-00020","article-title":"Unmasking of the hypotensive effect of nifedipine in normotensives by addition of the angiotensin converting enzyme inhibitor benazepril","volume":"10","author":"Jakobsen","year":"1992","journal-title":"J. Hypertens."},{"key":"10.1016\/j.nephro.2007.04.002_bib66","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib67","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/00004872-200211000-00001","article-title":"Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials?","volume":"20","author":"Zanchetti","year":"2002","journal-title":"J. Hypertens."},{"key":"10.1016\/j.nephro.2007.04.002_bib68","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","article-title":"Blood pressure control, proteinuria, and the progression of renal disease. The modification of diet in renal disease study","volume":"123","author":"Peterson","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.nephro.2007.04.002_bib69","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ki.1989.190","article-title":"Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril","volume":"36","author":"Heeg","year":"1989","journal-title":"Kidney Int."},{"key":"10.1016\/j.nephro.2007.04.002_bib70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/ndt\/14.1.98","article-title":"Antiproteinuria efficacy of verapamil in comparison to trandolapril in non-diabetic renal disease","volume":"14","author":"Hemmelder","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.nephro.2007.04.002_bib71","first-page":"410","article-title":"Randomized double blinded trial of enelapril versus hydrochlorothiazide on GFR in diabetic nephropathy","volume":"22","author":"Walker","year":"1993","journal-title":"Hypertension"},{"key":"10.1016\/j.nephro.2007.04.002_bib72","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nephro.2007.04.002_bib73","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nephro.2007.04.002_bib74","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-Converting Enzyme Inhibitor - associated elevation in serum creatinine. Is this a cause of concern?","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.nephro.2007.04.002_bib75","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM200007203430304","article-title":"Prevention of radiographic-contrast-agent-induced reduction in renal function by acetylcysteine","volume":"343","author":"Tepel","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nephro.2007.04.002_bib76","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1056\/NEJM199406303302603","article-title":"Diuretic therapy for hypertension and the risk of primary cardiac arrest","volume":"330","author":"Siscovick","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nephro.2007.04.002_bib77","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200003303421301","article-title":"for the atherosclerosis risk in communities study: Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus","volume":"342","author":"Gress","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nephro.2007.04.002_bib78","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/01.HYP.14.2.210","article-title":"Smoking accounts for adverse effect of antihypertensive medications on plasma lipids","volume":"14","author":"Halkin","year":"1989","journal-title":"Hypertension"},{"key":"10.1016\/j.nephro.2007.04.002_bib79","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bmj.291.6488.97","article-title":"MRC Working Party: MRC trial of treatment of mild hypertension. Principal results","volume":"291","year":"1985","journal-title":"Br. Med. J."},{"key":"10.1016\/j.nephro.2007.04.002_bib80","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(98)08127-6","article-title":"Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials","volume":"353","author":"Gueyffier","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib81","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1097\/00004872-200312000-00030","article-title":"Results of the pilot study for the Hypertension in the Very Elderly Trial","volume":"21","author":"Bulpitt","year":"2003","journal-title":"J. Hypertens."},{"key":"10.1016\/j.nephro.2007.04.002_bib82","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib83","first-page":"710","article-title":"Post-stroke antihypertensive treatment study. A preliminary result. PATS Collaborating Group","volume":"108","year":"1995","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.nephro.2007.04.002_bib84","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease","volume":"163","author":"Tzourio","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.nephro.2007.04.002_bib85","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archneur.63.5.noc60013","article-title":"Welsh-Bohmer KA, Breitner JC: Antihypertensive medication use and incident Alzheimer disease: the Cache County Study","volume":"63","author":"Khachaturian","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nephro.2007.04.002_bib86","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11906-004-0070-0","article-title":"Prevention of dementia and cerebroprotection with antihypertensive drugs","volume":"6","author":"Hanon","year":"2004","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.nephro.2007.04.002_bib87","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1053\/euhj.1999.1534","article-title":"Diuretic therapy and renal cell carcinoma: another controversy","volume":"20","author":"Messerli","year":"1999","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.nephro.2007.04.002_bib88","series-title":"Les diur\u00e9tiques","first-page":"119","article-title":"Effets art\u00e9riolaires des diur\u00e9tiques","author":"Freslon","year":"1998"},{"key":"10.1016\/j.nephro.2007.04.002_bib89","series-title":"Les diur\u00e9tiques","first-page":"155","article-title":"Les diur\u00e9tiques dans le traitement de l'hypertension art\u00e9rielle: m\u00e9canisme de l'action antihypertensive et utilisation clinique","author":"Girerd","year":"1998"},{"key":"10.1016\/j.nephro.2007.04.002_bib90","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.HYP.33.4.1043","article-title":"Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide","volume":"33","author":"Pikkers","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.nephro.2007.04.002_bib91","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00004872-199917080-00004","article-title":"Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial","volume":"17","author":"Millar","year":"1999","journal-title":"J Hyperten"},{"key":"10.1016\/j.nephro.2007.04.002_bib92","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/hy1001.096212","article-title":"Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial","volume":"38","author":"Cushman","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.nephro.2007.04.002_bib93","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00005344-199810000-00023","article-title":"Twenty four hour antihypertensive efficacy of indapamid 1.5 mg sustained release: results of 2 randomized double-blind controlled studies","volume":"32","author":"Mallion","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.nephro.2007.04.002_bib94","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0895-7061(98)00268-4","article-title":"Low dose bendrofluazide (1,25\u00a0mg) effectively lowers blood pressure over 24\u00a0h. Results of a randomized, double blind, placebo controlled cross over study","volume":"12","author":"Wiggam","year":"1999","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.nephro.2007.04.002_bib95","series-title":"Les diur\u00e9tiques","first-page":"211","article-title":"Bith\u00e9rapies antihypertensives comprenant un diur\u00e9tique en combinaison fixe","author":"Laurent","year":"1998"},{"key":"10.1016\/j.nephro.2007.04.002_bib96","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(98)07614-4","article-title":"Optimisation of antihypertensive treatment by crossover rotation of four major classes","volume":"353","author":"Dickerson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.04.002_bib97","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/jama.289.16.2073","article-title":"Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial","volume":"289","author":"Black","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2007.04.002_bib98","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs non calcium-antagonist hypertension treatment strategy for patients with coronary artery disease. The International verapamil trandolapril study (INVEST). A randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2007.04.002_bib99","first-page":"216","article-title":"Lithiase calcique idiopathique: correction di\u00e9t\u00e9tique des facteurs de risque m\u00e9tabolique","volume":"27","author":"Fournier","year":"1998","journal-title":"Presse Med."},{"key":"10.1016\/j.nephro.2007.04.002_bib100","series-title":"Proceedings of Urolithiasis","article-title":"Long-term effect of thiazide and normalization of dairy product intake on bone mineral density, calciuria and bone resorption in calcium stone formers with idiopathic calciuria","author":"Bataille","year":"2000"},{"key":"10.1016\/j.nephro.2007.04.002_bib101","first-page":"303","article-title":"Les essais cliniques randomis\u00e9s dans la pr\u00e9vention des lithiases calciques","volume":"24","author":"Presne","year":"2003","journal-title":"Nephrologie"},{"key":"10.1016\/j.nephro.2007.04.002_bib102","first-page":"106","article-title":"Thiazides diuretics and fractures: can metaanalysis help?","volume":"20","author":"Jones","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.nephro.2007.04.002_bib103","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1046\/j.1523-1755.2000.00221.x","article-title":"Comparative effect of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion","volume":"50","author":"Frasetto","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.nephro.2007.04.002_bib104","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/ndt\/15.12.1903","article-title":"New insight into the paradoxical effect of thiazides in diabetes insipidus therapy","volume":"15","author":"Magaldi","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.nephro.2007.04.002_bib105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/bmj.321.7256.267","article-title":"Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review","volume":"321","author":"Dumont","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.nephro.2007.04.002_bib106","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/01.STR.31.8.1904","article-title":"Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking","volume":"31","author":"Chabriat","year":"2000","journal-title":"Stroke"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725507000831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725507000831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2007.04.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T13:54:15Z","timestamp":1741182855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725507000831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":106,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S1769725507000831"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2007.04.002","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}